Abstract
There is currently insufficient evidence to support the use of COX‐2 inhibitors in treating chronic hepatitis or in preventing liver fibrosis
MeSH terms
-
Animals
-
Chronic Disease
-
Cyclooxygenase 2 / physiology*
-
Cyclooxygenase 2 Inhibitors / therapeutic use*
-
Disease Models, Animal
-
Evidence-Based Medicine
-
Hepatitis / drug therapy
-
Hepatitis / enzymology*
-
Hepatitis, Animal / enzymology
-
Humans
-
Liver Cirrhosis / prevention & control
-
Mice
Substances
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase 2